orthostatic hypotension

  1. Mij

    Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension, 2021, Horacio Kaufmann et al

    Phase 2 trial: Abstract Purpose In neurogenic orthostatic hypotension, blood pressure falls when upright owing to impaired release of norepinephrine, leading to dizziness. Ampreloxetine, a selective norepinephrine reuptake inhibitor, increases circulating norepinephrine levels. This study...
  2. Andy

    Autonomic dysfunction in post-COVID patients with & witfhout neurological symptoms: a prospective multidomain observational study, 2021, Stella et al

    Abstract The autonomic nervous system (ANS) can be affected by COVID-19, and dysautonomia may be a possible complication in post-COVID individuals. Orthostatic hypotension (OH) and postural tachycardia syndrome (POTS) have been suggested to be common after SARS-CoV-2 infection, but other...
  3. M

    Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome

    Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome Abstract: Rationale: Orthostatic hypotension is a common clinical problem, but the underlying mechanisms have not been fully delineated. Objective: We describe two families, with four patients in total, suffering from...
Back
Top Bottom